---
title: "Velocity-dependent friction model explains theta–gamma phase–amplitude coupling"
id: "biorxiv-12-velocity-dependent-friction-in-a-simple-two-oscillator-system-i-phase-amplitude"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-12-velocity-dependent-friction-in-a-simple-two-oscillator-system-i-phase-amplitude"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1?rss=1"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Velocity-dependent friction model explains theta–gamma phase–amplitude coupling
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-12-velocity-dependent-friction-in-a-simple-two-oscillator-system-i-phase-amplitude
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1?rss=1)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators derived a reduced model from a generalized **Langevin equation** to explain theta–gamma phase amplitude coupling (PAC) without assigning mechanism to specific cell types. - The framework treats unobserved neural activity as effective friction and noise; both stiffness and friction are expanded to first order in theta and gamma variables. - Expanding those state-dependent terms yields ten interaction terms; the study team observed that only two friction-like terms change gamma energy and therefore produce PAC. - Depending on sign and form, the friction terms position gamma bursts at theta peak, trough, rising phase or falling phase — the coupling determines burst-phase preference. - The authors analyzed a simplified example in which gamma friction follows theta velocity; because theta velocity integrates to theta coordinate, gamma amplitude varies as exp(gvvxθ/2), tying amplitude to theta coordinate. - The fluctuation dissipation theorem maps noise and damping onto a **theta** effective temperature; PAC strength reduces to a closed-form function of a single dimensionless parameter, kappa. - Without parameter fitting, this prediction matched 51,095 simulated records (R2 = 0.993). - Median PAC across 5,160 combinations of coupling and damping also fit the closed-form prediction (R2 = 0.989). - The coupling drives gamma out of equilibrium: investigators reported gamma kinetic temperature rising well above the temperature inferred from its linear response. - All interaction coefficients enter linearly in the reduced equations, so the authors note they can, in principle, be estimated from recordings using linear regression. - The companion paper, cited by the authors, links the same dimensionless number to the proximity of a dynamical stability boundary.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=opvWHSwLQwg5f3vNw0xMVcsnaLUJ8EIzhNoxfSmtQ0E-1795202413.9402401-1.2.1.1-gcELAboiResyX6mJRIjA105XXCTZIi.BvPXn67znwb5Fkr_AWkmFPbbozruf5kjd) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Velocity-dependent friction in a simple two-oscillator system. I. Phase amplitude coupling [ View ORCID Profile](http://orcid.org/0009-0001-8335-1855)YuHan Luo, Sonali Priyadarshini Nayak, Murielle Hsu, Greg Worrell, [ View ORCID Profile](http://orcid.org/0000-0002-8343-0406)David Hsu doi: https://doi.org/10.64898/2026.11.18.767449 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. YuHan Luo 1 University of Wisconsin-Madison; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=YuHan%2BLuo%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Luo%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AYuHan%2BLuo%2B) * [ORCID record for YuHan Luo](http://orcid.org/0009-0001-8335-1855 "Open in new tab") * For correspondence: yuhanluo33@gmail.com Sonali Priyadarshini Nayak 2 Department of Chemistry, Boston University; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sonali%2BPriyadarshini%2BNayak%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Nayak%20SP&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ASonali%2BPriyadarshini%2BNayak%2B) Murielle Hsu 3 Department of Neurology, University of Wisconsin School of Medicine and Public Health; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Murielle%2BHsu%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hsu%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMurielle%2BHsu%2B) Greg Worrell 4 Mayo Clinic * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Greg%2BWorrell%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Worrell%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AGreg%2BWorrell%2B) David Hsu 3 Department of Neurology, University of Wisconsin School of Medicine and Public Health; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=David%2BHsu%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hsu%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ADavid%2BHsu%2B) * [ORCID record for David Hsu](http://orcid.org/0000-0002-8343-0406 "Open in new tab") * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5981142/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5981142/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5981142/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5981142/1) * [Data/Code](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1.external-links)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_data_code/node:5981142/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5981142/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Cortical gamma oscillations often arrive in bursts locked to the phase of slower theta waves, a pattern called theta gamma phase amplitude coupling (PAC). PAC is linked to memory and altered in epilepsy, but most models tie it to particular cells or circuits. We start from a generalized Langevin equation, an equation of motion for a few collective variables in which friction and random forces stand for the unobserved neural activity, and let its stiffness and friction depend on the state. Expanding them to first order in the theta and gamma variables yields ten possible interaction terms; only the two friction type terms change gamma energy and produce PAC, and depending on the term and its sign the gamma bursts sit at the peak, trough, rising or falling phase of theta. We study a gamma friction that follows theta velocity as a simplified example. Because the time integral of theta velocity is theta coordinate, the gamma amplitude rises and falls with theta coordinate as exp(gvvxθ/2). The fluctuation dissipation theorem turns noise and damping into a theta effective temperature, and the PAC strength becomes a closed form function of one dimensionless number, kappa , that combines the coupling with this temperature. Without fitted parameters, this prediction accounts for 51,095 simulated records (R2 = 0.993) and for the median PAC of 5,160 combinations of coupling and damping (R2 = 0.989). The coupling also drives gamma out of equilibrium: its kinetic temperature grows far above the one inferred from its response. All coefficients enter linearly so that they can, in principle, be estimated from recordings by linear regression. A companion paper shows that the same number sets the distance to a stability boundary. ### Competing Interest Statement The authors have declared no competing interest. ## Footnotes * Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.11.19.767710v1 "Dual C5aR1 and C5aR2 deficiency uncouples neutrophilic inflammation from antibacterial host defense")[Next ](https://www.biorxiv.org/content/10.64898/2026.11.18.767047v1 "The creatine transporter SLC6A8 is an immune pressure-exposed metabolic vulnerability in acute myeloid leukemia") Posted November 20, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/11/20/2026.11.18.767449.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.11.18.767449v1.supplementary-material) [ Data/Code](https://www.biorxiv.org/content/early/2026/11/20/2026.11.18.767449.external-links) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) Velocity-dependent friction in a simple two-oscillator system. I. Phase amplitude coupling YuHan Luo, Sonali Priyadarshini Nayak, Murielle Hsu, Greg Worrell, David Hsu bioRxiv 2026.11.18.767449; doi: https://doi.org/10.64898/2026.11.18.767449 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.18.767449v1%26text%3DVelocity-dependent%2520friction%2520in%2520a%2520simple%2520two-oscillator%2520system.%2520I.%2520Phase%2520amplitude%2520coupling "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.18.767449v1%26t%3DVelocity-dependent%2520friction%2520in%2520a%2520simple%2520two-oscillator%2520system.%2520I.%2520Phase%2520amplitude%2520coupling "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.18.767449v1%26title%3DVelocity-dependent%2520friction%2520in%2520a%2520simple%2520two-oscillator%2520system.%2520I.%2520Phase%2520amplitude%2520coupling%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.11.18.767449v1%26title%3DVelocity-dependent%2520friction%2520in%2520a%2520simple%2520two-oscillator%2520system.%2520I.%2520Phase%2520amplitude%2520coupling "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.11.18.767449) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (46166) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20382) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27662) * [Clinical Trials](https://www.biorxiv.org/co
## Related Clinical Research

- [Velocity-dependent friction controls theta–gamma coupling and stability in a two-oscillator model](https://medichelpline.com/clinical-feed/biorxiv-13-velocity-dependent-friction-in-a-simple-two-oscillator-system-ii-regions-of.md)
- [NeuroSim: Multi-disorder EEG Simulator for Personalized Pattern Injection and AI Modeling](https://medichelpline.com/clinical-feed/biorxiv-5-neurosim-a-clinically-informed-multi-disorder-eeg-simulator-with-personalized.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)
- [Psychotropic drug prescribing trends in Dutch nursing home residents with dementia, 2016–2023](https://medichelpline.com/clinical-feed/plos-one-17-trends-in-psychotropic-drug-use-in-nursing-home-residents-with-dementia-and.md)
- [fMRI-based ARC tool differentiates SuperAgers from Alzheimer’s with strong AUC](https://medichelpline.com/clinical-feed/medical-news-today-2-new-brain-imaging-tool-distinguishes-between-alzheimer-s-disease-and-superagers.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.